NHS programme to reduce brain injuries in childbirth to be rolled out nationally
The Avoiding Brain Injury in Childbirth (ABC) programme will help maternity staff to better identify signs that the baby is in distress during labour so they can act quickly, the Department of Health and Social Care (DHSC) said.
It will also help staff respond more effectively to obstetric emergencies, such as where the baby's head becomes lodged deep in the mother's pelvis during a caesarean birth, the DHSC added.
The Government programme, which will begin from September and follows a development phase and pilot scheme, will reduce the number of avoidable brain injuries during childbirth – helping to prevent lifelong conditions like cerebral palsy, according to the DHSC.
Health Secretary Wes Streeting said: 'All expectant mothers giving birth in an NHS hospital should have peace of mind that they are in safe hands.
'This vital programme will give staff across the country the right tools and training to deliver better care to women and their babies, reducing the devastating impact of avoidable brain injuries.
'Under our Plan for Change, we are supporting trusts to make rapid improvements and training thousands more midwives – but I know more needs to be done. We will put women's voices right at the heart of our reforms as we work to improve care.'
The national rollout follows a pilot in 12 maternity units that was launched in October and delivered by the Royal College of Obstetricians and Gynaecologists, Royal College of Midwives (RCM) and The Healthcare Improvement Studies Institute.
The pilot has shown the programme will fill a gap in current training by bringing multi-disciplinary teams together to work more collaboratively to improve outcomes, the DHSC said.
It added that the programme will give clinicians more confidence to take swift action in managing an emergency during labour.
It is expected to reduce inequalities in maternity outcomes across England – so that most maternity units achieve outcomes comparable to the highest-performing 20% of trusts.
Ranee Thakar, president of the Royal College of Obstetricians and Gynaecologists (RCOG), said: 'The ABC programme supports multi-disciplinary maternity teams to deliver safer, more personalised care.
'Hundreds of maternity staff, including obstetricians, midwives and anaesthesiologists have been involved in developing and testing this quality improvement programme.
'We have heard what a difference it makes, supporting teams to work effectively together in time-sensitive and high-pressure situations. The RCOG is extremely proud to have been part of this fantastic collaboration.'
Gill Walton, Royal College of Midwives chief executive, said: 'Every midwife, maternity support worker, obstetrician, anaesthetist and sonographer wants to provide good, safe care – and the best way to do that is by working and training together. The ABC programme has brought together all those involved in maternity care, offering practical solutions to some of the most acute clinical challenges.
'Crucially the ABC programme tools and training have been developed based on the voices of women, families and maternity staff. This has been the key to the success of the pilot programme.
'Equally the will and drive of midwives and the wider multi-disciplinary team to improve safety and outcomes for women and their families has been evident across the course of the training at the pilot sites.'
Professor Mary Dixon-Woods, director of The Healthcare Improvement Studies Institute, said: 'The ABC programme design is based on the principle that evidence-based, co-designed patient-focused standardisation of clinical practice can reduce unwarranted variation and improve care and outcomes.
'Crucially, this needs to be supported by comprehensive improvement resources, including training, tools and assets to enable good clinical practice and teamwork and respectful and inclusion communication and decision-making with women and birth partners.
'The pilot has shown that it's possible to train people effectively and efficiently. A national commitment to implement the programme at scale will be important in ensuring that the benefits are seen.'
Professor Donald Peebles, national clinical director for maternity, NHS England, said: 'The national implementation of the ABC programme will make a huge difference to babies and their families, helping to prevent the devastating impact of avoidable brain injuries and ensure more healthy babies are returning home with their families.
'This is hugely welcome news for maternity teams across the country who are set to benefit from this important training programme that will help ensure women and babies receive high quality, safe and personalised care.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
16 hours ago
- Telegraph
Long-term sickness has made economy 10pc smaller
The long-term sickness crisis means Britain's economy is 10 per cent smaller than it otherwise would be, according to a report produced for the NHS. Tackling ill-health, increasing employment rates and preventing premature deaths by making better use of innovation in the health service would give Britain a £246 billion boost – equivalent to around a 10th of GDP – according to research by Frontier Economics, a consultancy firm. Wes Streeting, the Health Secretary, hailed the 'landmark study' as evidence of what the NHS could achieve 'if we harness the massive potential at our fingertips'. It comes as Rachel Reeves, the Chancellor, is set to gamble on the NHS to boost growth in this week's spending review, with a £30 billion funding uplift at the expense of other public services. This equates to an around £17 billion real-terms increase over the next three years and comes after a £22 billion rise was announced in October, with Sir Keir Starmer having pinned the success of his premiership on eliminating the 7.42 million NHS backlog. The new research found the 'size of the prize' for getting the 4.2 million unemployed people with long-term sickness back into work would increase GDP by £125 billion alone. It further found that reducing the number of sick days employees take, in particular those on long-term sick leave from work, would provide an extra £45 billion. It said that 'reducing long-term absences by 20 per cent would be worth nearly £10 billion', for example. The remainder of the economic benefits came through delaying the 132,000 early deaths that occur to working-age people each year because of preventable diseases such as heart attacks, increasing the hours of people who work part-time because of a 'work-limiting health condition', and reducing the 'in-work productivity' lost to sickness. It means the 'total productivity impact of reducing ill-health on the UK economy is up to £246 billion', which equates to '9.62 per cent of GDP', the researchers said. The study, commissioned by the Health Innovation Network, which includes NHS and health industry leaders, said there were four major causes of sickness impacting the health service and driving worklessness. These were mental health, which alone accounts for almost £50 billion in lost productivity, musculoskeletal conditions such as arthritis and back pain, heart disease and lung-related conditions. Simple measures to identify and treat high cholesterol and high blood pressure, for example, could add more than £2 billion to the economy, it said, which could include treating more people with cheap statins sooner. It also found potential productivity gains increased to £278 billion if the UK could reduce sickness and absence among the NHS workforce and increase the amount of foreign investment. It said the UK was lagging behind France and Germany when it comes to research and clinical trials, as well as the number of skilled workers and pharmaceutical employees. Mr Streeting said: 'We often talk about the challenges associated with health care in this country, but this report shows there are lots of opportunities too if we harness the massive potential at our fingertips. 'The NHS is uniquely placed to take advantage of innovation, and this landmark study reveals the prize on offer – potential benefits worth £246 billion annually and the ability to free up 233 million hours for our NHS workforce, proving that health innovation isn't just good for patients, it's vital for our economy and the taxpayer. 'By focusing on key conditions like mental health and cardiovascular disease, and embracing AI, telemedicine and genomic research, we can improve patient outcomes while creating high-skilled jobs and attracting global investment.' He said the findings of the research would 'help inform our mission to build a health service that delivers for patients and contributes to a stronger economy'. One of the key health issues driving increases in heart disease, cancer and joint and bone conditions is obesity. A new trial revealed by The Telegraph last year is examining whether weight-loss jab Mounjaro can reduce unemployment and workplace absence levels in Greater Manchester. That study, led by Health Innovation Manchester and pharmaceutical firm Lilly, is part of plans to explore how to reduce the £3.2 billion impact of obesity on Manchester's economy. Professor Ben Bridgewater, chief executive of Health Innovation Manchester, said: 'There is so much potential for health innovation to make lives better for people, save the NHS money and increase the country's workforce productivity. 'We know that the massive impact innovation in obesity can make for the people and economy of Greater Manchester. We are excited about this new report that quantifies just how large an opportunity exists nationally from innovation in health care.' The new research paper, called Defining the Size of the Health Innovation Prize, also said that as ill-health is predicted to increase with time, the potential productivity gains from preventing it and keeping people in work increases too. The researchers estimate by 2035 the GDP lost to ill-health - as things stand - will be between £283 billion and £332 billion. Matthew Taylor, chief executive of the NHS Confederation, said the report showed what could be achieved, but that 'more needs to be done to fully realise the potential of innovation' and that NHS leaders had told them 'a lack of time, funding that supports long-term implementation and scaling along with inadequate infrastructure is limiting their ability to seek new ideas and embed at scale those already in the system'. He said innovation 'needs be managed in a way that works for those working across the NHS' and would 'require a skilled digital and innovation team and a wider workforce to support adoption' and appropriate infrastructure.
Daily Mirror
a day ago
- Daily Mirror
New ‘Star Wars' cancer treatment which pulverises tumours with sound waves
The NHS is set to become the only health system in Europe to use ground-breaking histotripsy technology, which removes the need for surgery by firing pulses to form micro bubbles from gases A 'Star Wars' treatment which zaps hard-to-reach cancers using sound waves is being trialled on the NHS. The technology, called histotripsy, removes the need for surgery and instead fires pulses to form micro bubbles from gases within the tumour. These 'bubble clouds' expand and contract in microseconds to destroy the cancer cells. The targeted ultrasound technology currently only available in the US will now be trialled by the NHS on liver cancer patients in Cambridge. If successful regulators say it will be a 'a major step forward' which it is hoped could be used to destroy pancreatic and kidney cancers. The Government says Health Secretary Wes Streeting intervened to authorise controlled early access to the device, as part of a new Innovative Devices Access Pathway (ADIP) programme. Mr Streeting, who previously had kidney cancer, told the Mirror: 'I've slashed red tape, so NHS patients will be the first in Europe to benefit from a revolutionary and non-invasive liver cancer treatment – that uses ultrasound technology to destroy tumours - years earlier than planned. "Patients stand to see faster recovery times, fewer dangerous complications, and shorter hospital stays. We are slashing red tape, so game-changing new treatments reach the NHS front line quicker.' In contrast to invasive surgery, the targeted ultrasound can take just 30 minutes with 'limited or no pain' and involves a quick recovery. It destroys tissue at cellular and sub-cellular levels while avoiding the ionising damage of radiation or the heat damage from thermal treatments. The bubble clouds cause the cancerous mass to break apart, destroying tumor cells and leaving the debris to be eliminated by the immune system. US cancer expert Dr Jennifer Linehan, of St John's Cancer Institute, said the device could in future also be used to pulverise prostate and bladder cancers. She said: 'This technology kills tumours without even touching you. Sometimes when I'm talking to patients I tell them this is ' Star Wars technology' because there are no cuts, there's no poking, there's nothing that's going inside you from outside. It's all happening with a focused beam of ultrasound to destroy the tumours.' The first cancer patients in Europe to access the treatment under such a scheme will be treated for their liver cancer at Addenbrooke's Hospital in Cambridge this summer. The machine, manufactured by HistoSonics, is expected to be fully installed later this year, where it will be used initially to treat patients with primary and secondary liver tumours. Wider research on how this could potentially treat tumours in other organs is underway. James Pound, innovation director at the Medicines and Healthcare products Regulatory Agency (MHRA), said: 'We've shown we can get promising technologies to patients faster without compromising safety. It's a major step forward for patients with liver cancer and shows how the UK can be a frontrunner in supporting responsible innovation that meets real clinical need.' Patients undergoing histotripsy are given general anesthesia to control breathing and to minimize movements of targeted tumours An evaluation of the NHS pilot will be published later this year by the Department of Health and Social Care. Histotripsy has already been approved to treat liver tumors by the US Food and Drug Administration (FDA). Roland Sinker, Chief Executive of Cambridge University Hospitals said: 'Histotripsy is an exciting new technology that will make a huge difference to patients. By offering this non-invasive, more targeted treatment we can care for more people as outpatients and free up time for surgeons to treat more complex cases. 'The faster recovery times mean patients will be able to return to their normal lives more quickly, which will also reduce pressure on hospital beds, helping us ensure that patients are able to receive the right treatment at the right time.' Wes Streeting - Secretary of State for Health and Social Care As a cancer survivor, I know what an incredible impact medical technology can have. After I was diagnosed with kidney cancer, I was treated by a world-class surgeon equipped with a robot. Together, they saved my life. The NHS is abuzz with innovation and creativity. We're already witnessing the trial of an AI-driven blood test to spot common cancers, the roll-out of a game-changing system to bring cancer patients' data together, and the unprecedented expansion of the NHS app. It is my job to put the wind in the sails and give the world's greatest minds the freedom to unleash tomorrow's tech. To strengthen Britain's role as a global leader, those innovators must be freed from the shackles of stifling regulatory processes. Of course, we need to keep patients safe, but technology is moving quickly, and so must we. That's why I've already slashed red tape, so NHS patients will be the first in Europe to benefit from a revolutionary and non-invasive liver cancer treatment – developed by US-based company HistoSonics – that uses ultrasound technology to destroy tumours, years earlier than planned. Patients stand to see faster recovery times, fewer dangerous complications, and shorter hospital stays. Soon, we will publish the 10 Year Health Plan – a once in a generation strategy to save and rebuild the NHS, delivering a health service fit for the future. This government will unleash innovation to speed the shift from analogue to digital, and tackle the bureaucracy holding back our public services No longer will the creativity needed to bring our NHS into the modern age be stifled. Through our Plan for Change, we will get the latest tech to our NHS frontline, put patients first and develop a 21st century health service that's, once again, the envy of the world.
Telegraph
a day ago
- Telegraph
The NHS and Royal Mail are a match made in hell
Your bank doesn't send letters ticking you off about your overdraft anymore. Neither does your lawyer, or your accountant, or anyone else for that matter. Even your birthday or Christmas cards typically arrive via your phone's inbox instead of the front door. There is, however, one organisation that still finds a piece of paper delivered by hand to be the most efficient way to communicate: the NHS. Its spending on the Royal Mail is still soaring – with taxpayers footing the bill. The Health Secretary Wes Streeting may still trot out his standard speech about how the NHS is a global leader in new technologies and how Artificial Intelligence will drive a new era of productivity. The reality, as so often, turns out to be very different. We learned this week that the technology that the health service relies on is one from the 1840s: the letter with a stamp on it. Despite pledging to switch to a completely digital way of communicating with patients, according to research from the Taxpayer's Alliance the amount the health service spent on mail punched through £100 million this year, up by 12.5 per cent over the last twelve months. Even though up to a quarter of the estimated eight million missed appointments a year were the fault of delays in the post, hospital managers persist in using letters as their main form of managing the system. The last quarter of a century of technological progress has completely passed it by. Indeed, at the current rate of growth the NHS will be spending £180 million a year by the end of the decade on the postal service, and more than £500 million by the 2040s. Perhaps the takeover of the mail system by the Czech billionaire Daniel Kretinsky makes sense after all. While most of us may have imagined the postal business was in terminal decline, perhaps there is a fortune to be made as the booking system of the NHS. The trouble is that it should hardly come as a surprise to anyone. In reality, the NHS and Royal Mail are perfect partners for each other. They are both relics of a different era, created at a time when we still believed that government-owned monopolies were the most effective way to deliver a product or a service. They are both hopelessly inefficient and riddled with restrictive practices. They are both dominated by trade unions that are resistant to change; that protect their privileges with a single-minded determination; and bask in a sense of entitlement that justifies everything they do. And they are both completely resistant to new technology, even if it could transform both the quality and the efficiency of the service they are meant to be delivering. They could both move with the times if they wanted to. But it would cause too much inconvenience for the staff. Instead, they are perfectly happy to prop each other up – with the long-suffering taxpayer left to foot the bill for both of them.
